TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression
- PMID: 39161768
- PMCID: PMC11330819
- DOI: 10.3389/fimmu.2024.1433321
TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression
Abstract
TANK-binding kinase 1 (TBK1) is a member of the IKK family and plays a crucial role in the activation of non-canonical NF-κB signaling and type I interferon responses. The aberrant activation of TBK1 contributes to the proliferation and survival of various types of tumor cells, particularly in specific mutational or tumorous contexts. Inhibitors targeting TBK1 are under development and application in both in vivo and in vitro settings, yet their clinical efficacy remains limited. Numerous literatures have shown that TBK1 can exhibit both tumor promoting and tumor inhibiting effects. TBK1 acts as a pivotal node within the innate immune pathway, mediating anti-tumor immunity through the activation of innate immune responses. Facilitating interferon-I (IFN-I) production represents a critical mechanism through which TBK1 bridges these processes. IFN has been shown to exert both beneficial and detrimental effects on tumor progression. Hence, the paradoxical role of TBK1 in tumor development may necessitate acknowledgment in light of its downstream IFN-I signaling cascade. In this paper, we review the signaling pathways mediated by TBK1 in various tumor contexts and summarize the dual roles of TBK1 and the TBK1-IFN pathways in both promoting and inhibiting tumor progression. Additionally, we highlight the significance of the TBK1-IFN pathway in clinical therapy, particularly in the context of immune response. We anticipate further advancements in the development of TBK1 inhibitors as part of novel cancer treatment strategies.
Keywords: IFN-I; TBK1; TBK1 inhibitor; immunotherapy; innate immunity.
Copyright © 2024 Wang, Zhang, Wu and Ji.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The Ca2+-dependent phosphatase calcineurin dephosphorylates TBK1 to suppress antiviral innate immunity.J Virol. 2024 May 14;98(5):e0001624. doi: 10.1128/jvi.00016-24. Epub 2024 Apr 2. J Virol. 2024. PMID: 38563732 Free PMC article.
-
The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.Microbiol Spectr. 2021 Dec 22;9(3):e0145821. doi: 10.1128/Spectrum.01458-21. Epub 2021 Dec 15. Microbiol Spectr. 2021. PMID: 34908452 Free PMC article.
-
Crosstalk and Prospects of TBK1 in Inflammation.Immunol Invest. 2024 Nov;53(8):1205-1233. doi: 10.1080/08820139.2024.2392587. Epub 2024 Aug 28. Immunol Invest. 2024. PMID: 39194013 Review.
-
Human Metapneumovirus Induces IRF1 via TANK-Binding Kinase 1 and Type I IFN.Front Immunol. 2021 Jun 24;12:563336. doi: 10.3389/fimmu.2021.563336. eCollection 2021. Front Immunol. 2021. PMID: 34248923 Free PMC article.
-
The role of TBK1 in cancer pathogenesis and anticancer immunity.J Exp Clin Cancer Res. 2022 Apr 9;41(1):135. doi: 10.1186/s13046-022-02352-y. J Exp Clin Cancer Res. 2022. PMID: 35395857 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous